Ultromics
ultromics.com
As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Financials
Overview
Ultromics is an Oxford company founded in 2017 that applies machine learning to echocardiography. Its EchoGo software detects heart failure and coronary disease patterns that are easy for clinicians to miss on ultrasound images. The company holds American regulatory clearances and works with hospitals in Britain and the United States.
News
Ultromics nets $55M to boost its AI ultrasound software for detecting hidden heart failure
Read more
Report
Ultromics Limited
The Nature Index tracks the affiliations of scientific articles from high-quality publications. The research profile for Ultromics Limited reflects the research output of authors from Ultromics Limited who published articles in the 145 journals included i
Read more
Report
Ultromics' ultrasound AI scores FDA clearance for spotting heart failure with preserved ejection fraction
Read more
Report
Caption Health and Ultromics Partner to Put Heart Disease Detection and Management Tools in More Hands
BRISBANE, Calif., OXFORD, England and GUILFORD, Conn., Nov. 9, 2021/ PRNewswire/-- Caption Health and Ultromics, leaders in using AI to improve heart ultrasound diagnostics, today announced a strategic partnership to accelerate cardiovascular disease dete
Read more
Report
Pro access
Upgrade to see all 7 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.